Belite Bio Inc

Belite Bio Inc

World Rank (Aug-2026)
3042
Market Cap (Aug-2026)
6.405 Billion USD
World Rank (Jan-05-2024)
7,954
Market Cap (Jan-05-2024)
1.137 Billion USD
World Rank (Jul-30-2023)
11,043
Market Cap (Jul-30-2023)
0.656 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
BLTE
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Operating Income in USD
-84 Million USD
Annual Net Income in USD
-78 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
781 Million USD
Total Liabilities in USD
10 Million USD
Total Equity in USD
770 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Biopharmaceutical
Healthcare
Company Website
Belite Bio Inc
Company Profile
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on aging metabolic diseases including dry age related macular degeneration, liver disease and diabetes. The headquarters is in United States.
IPO Year
2022
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share